Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Open-Label Trial Comparing Two Avastin (Bevacizumab)-Based Treatment Regimens for the First-Line Treatment of Metastatic Colorectal Cancer

NCT00114946 is registered in ClinicalTrials.gov with Genentech, Inc. as lead sponsor.

NCT NCT00114946
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00114946 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Open-Label Trial Comparing Two Avastin (Bevacizumab)-Based Treatment Regimens for the First-Line Treatment of Metastatic Colorectal Cancer
Lead sponsor
Genentech, Inc.
Phase
Phase 4
Overall status
Terminated
Start date
May 31, 2005
Completion date
December 31, 2007
Enrollment
800
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer